All-cause mortality risk in older patients with femoral neck fracture.
Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jiang XY.
Li XP, et al. Among authors: jiang xy.
BMC Musculoskelet Disord. 2022 Oct 28;23(1):941. doi: 10.1186/s12891-022-05880-y.
BMC Musculoskelet Disord. 2022.
PMID: 36307783
Free PMC article.
Additionally, therapy with zoledronic acid 5 mg (Aclasta) was a protective factor (Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jiang XY, J Orthop Surg Res. 16:727, 2021). We wished to determine the risk factors for all-cause mortality in femoral neck fracture patients. …
Additionally, therapy with zoledronic acid 5 mg (Aclasta) was a protective factor (Li XP, Zhang P, Zhu SW, Yang MH, Wu XB, Jiang X …